학술논문

LBA34 Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S1273-S1274
Subject
Language
ISSN
0923-7534